An oral inhibitor of hypoxia-inducible factor (HIF) prolly hydroxylase that stimulates erythropoiesis and regulates iron metabolism.
Effective in correcting anemia in patients with chronic kidney disease.
It is also as effective as parenteral EPO in patients undergoing dialysis.